We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Understanding What Impacts Gut Microbiota Transplantation Success

Understanding What Impacts Gut Microbiota Transplantation Success

Understanding What Impacts Gut Microbiota Transplantation Success

Understanding What Impacts Gut Microbiota Transplantation Success

Credit: Pixabay.
Read time:

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Understanding What Impacts Gut Microbiota Transplantation Success"

First Name*
Last Name*
Email Address*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

The maintenance of healthy and resilient gut microbiota is critical for the quality of life and healthspan of the elderly. Fecal microbiota transplantation (FMT) has been widely used to restore healthy gut microbiota as part of the treatment of many gastrointestinal diseases. 

However, the effect of donor selection on the establishment and long-term stability of transplanted microbiota, especially in aged hosts, has been unclear. 

A research group led by Prof. DAI Lei at the Shenzhen Institute of Advanced Technology (SIAT) of the Chinese Academy of Sciences has attempted to clarify this matter. The group's recent research has found that microbiota transplanted from both autologous and heterologous donors could be established in aged hosts and facilitate microbiota restoration after perturbation by antibiotics.

However, the microbiota established by heterologous FMT is not resilient during chemical-induced colonic inflammation, in contrast to that of autologous FMT.

The study was published in iScience. 

The researchers treated naturally aged mice (20 months old, considered equivalent to approximately 60-year-old humans) with an antibiotic cocktail to disrupt their gut microbiota. The mice were then divided into three groups: those receiving FMT from autologous or heterologous donors and those receiving no FMT (spontaneous recovery). 

The spontaneous recovery group could not restore its microbiota diversity and composition by eight weeks. In contrast, both the autologous and heterologous FMT groups achieved restoration of gut microbiota diversity during this time. 

The microbiota from autologous and heterologous donors also had long-term effects (eight weeks after FMT) on the metagenomic gene pathways of the microbiota and the gene expression profiles of the host colon. 

Furthermore, the researchers disrupted the transplanted microbiota three weeks after FMT by using dextran sulfate sodium (DSS) to induce a self-limiting inflammation of the gut (colitis). 

They found that in the aged mice that had received autologous FMT, the transient perturbations in gut homeostasis caused by colitis did not affect the long-term stability of the transplanted microbiota. However, the gut microbiota of mice receiving heterologous FMT failed to withstand the perturbations, suggesting lower resilience. 

The study sheds light on the establishment and long-term dynamics of transplanted microbiota in aged hosts. It highlights the need to monitor the long-term stability of transplanted gut microbiota and perform multiple FMT as necessary. 

Reference: Wang Y, Tang J, Lv Q, et al. Establishment and resilience of transplanted gut microbiota in aged mice. iScience. 2022;25(1):103654. doi:10.1016/j.isci.2021.103654

This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source.